CN109336905A - The synthetic method of Cefazolin Intermediate TDA - Google Patents

The synthetic method of Cefazolin Intermediate TDA Download PDF

Info

Publication number
CN109336905A
CN109336905A CN201811581537.6A CN201811581537A CN109336905A CN 109336905 A CN109336905 A CN 109336905A CN 201811581537 A CN201811581537 A CN 201811581537A CN 109336905 A CN109336905 A CN 109336905A
Authority
CN
China
Prior art keywords
tda
cefazolin
synthetic method
aca
phosphate buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811581537.6A
Other languages
Chinese (zh)
Inventor
张艳红
张立明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zibo Xin Xin Medical Technology Service Co Ltd
Original Assignee
Zibo Xin Xin Medical Technology Service Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zibo Xin Xin Medical Technology Service Co Ltd filed Critical Zibo Xin Xin Medical Technology Service Co Ltd
Priority to CN201811581537.6A priority Critical patent/CN109336905A/en
Publication of CN109336905A publication Critical patent/CN109336905A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/187-Aminocephalosporanic or substituted 7-aminocephalosporanic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

The present invention relates to medical synthesis technical fields, and in particular to a kind of synthetic method of Cefazolin Intermediate TDA.The synthetic method of the Cefazolin Intermediate TDA is, using phosphate buffer and acetone as solvent, using 7-ACA and thiadiazoles as raw material, reacts under catalyst of triethylamine or ammonium hydroxide effect, obtains TDA.Synthetic method of the invention makees solvent by using phosphate buffer, to maintain the stabilization of reacting liquid pH value, it solves the problems, such as to add lye repeatedly because pH is reduced in reaction process, simple process, solvent are mild, reduce the use of organic solvent, the high income of the TDA of synthesis, purity is high, color are good.

Description

The synthetic method of Cefazolin Intermediate TDA
Technical field
The present invention relates to medical synthesis technical fields, and in particular to a kind of synthetic method of Cefazolin Intermediate TDA.
Background technique
Cefazolin sodium belongs to first generation cephalosporin class antibiotic, because its is cheap and therapeutic effect is good, in clinic On have a wide range of applications.TDA is the important intermediate for producing Cefazolin, and 7-amino-cephalosporanic acid 3 are contracted by thiadiazoles It closes chaining and forms TDA.The quality of TDA is most important to the purity and yield of Cefazolin sodium.Synthesis TDA common method master at present There are Aqueous phase and catalysis method, Aqueous phase takes water as a solvent, and alkali used is often sodium bicarbonate, ammonium hydroxide, triethylamine etc., this method cost Low, reaction condition is mild, and pollution is small, small to actual bodily harm;Catalysis method common solvent is acetonitrile, ether, tetrahydrofuran etc., yield 5-7% high compared with Aqueous phase, but that there are toxicity is big for used catalyst boron trifluoride, and by-product is difficult to recycle, and is unfavorable for environmental protection.
A kind of synthetic method of Cefazolin sodium Intermediate TDA is disclosed in patent CN201210112682.6, with acetone, Second is cured, ether, dimethyl carbonate, methylene chloride or chloroform are that solvent, 7-ACA and thiadiazoles are packed into according to the weight ratio of 1:1.2 In reaction vessel, it is passed through boron triflouride gas into reaction vessel, controls the temperature in reaction vessel between 0-50 DEG C, reaction It remains to 7-ACA less than 1% within 1-8 hours, crystallization is hydrolyzed to reactant using sodium carbonate, sodium bicarbonate or ammonium hydroxide, then Finished product TDA is obtained by suction filtration, washing and drying process.It is disclosed in patent CN20111024214.5 and a kind of prepares cephalo azoles The method of woods sodium compound uses dimethyl carbonate for solvent, and boron trifluoride is catalyst, the weight of 7-ACA and thiadiazoles 1:0.5 Amount ratio is reacted, and is carried out crystallization to reactant with ammonium hydroxide after reaction, using filter, washing, drying, is obtained TDA.It is above-mentioned Boron trifluoride catalyst is all made of in scheme, boron trifluoride is toxic and price is high, also needs to handle containing boride after reaction Waste, higher cost are not suitable for large-scale production.
A kind of synthetic method of Cefazolin Intermediate TDA is disclosed in patent CN201010014470.4, using cephalo Rhzomorph C is oxidized to GL-7-ACA through D-AAO, then reacts with 2- methyl-5-sulfydryl-1,3,4-thiadiazole, uses GL-7-ACA ACY sloughs glutaryl and obtains TDA.The technical solution uses biological enzyme reaction synthesis, environmentally protective nothing Pollution, solves the problems, such as that consumption of organic solvent is big in chemical production, but it needs first to synthesize GL-7-ACA, then synthesizes GL- TDA finally just synthesizes TDA, and synthesis step is more, and whole yield is lower, is unfavorable for industrialized production.
Therefore, seeking one kind, there is high yield, high quality, the simple synthetic method of reaction process to seem most important.
Summary of the invention
In view of the deficiencies of the prior art, the object of the present invention is to provide a kind of synthetic method of Cefazolin Intermediate TDA, Simple process, solvent are mild, reduce the use of organic solvent, the high income of the TDA of preparation is with high purity, and color is good.
The synthetic method of Cefazolin Intermediate TDA of the present invention, using phosphate buffer and acetone as solvent, with 7-ACA and thiadiazoles are raw material, react under the action of catalyst, obtain TDA;
The catalyst is triethylamine or ammonium hydroxide, preferably triethylamine.
Wherein, the mass ratio of 7-ACA and thiadiazoles is 1:0.5-1.
The mass ratio of 7-ACA and catalyst is 1:0.8-1.0.
Preferably, the synthetic method of the Cefazolin Intermediate TDA, comprising the following steps:
(1) it prepares phosphate buffer: buffer substance being dissolved in purified water, is shaken up, phosphate-buffered is made in constant volume Liquid, pH value 7.6-8.0.
(2) it synthesizes TDA: phosphate buffer and acetone being mixed, thiadiazoles and catalyst is sequentially added, is warming up to 60- 70 DEG C, 7-ACA is added, reacts 1.5-3h, adds Sodium Metabisulfite and EDTA, the reaction was continued to 7-ACA residual quantity < 1.0%, reaction terminates, and is down to room temperature, and it is 3.8-4.0 that dilute hydrochloric acid, which is added, and adjusts pH value, under the conditions of 20-25 DEG C, crystallization 30- 50min, then it is cooled to 0-5 DEG C, it filters, washes 2-3 times, acetone is washed 2-3 times, is dried in vacuo to get TDA product.
Buffer substance is one of potassium dihydrogen phosphate, sodium dihydrogen phosphate and disodium hydrogen phosphate, phosphoric acid hydrogen two in step (1) The mixture of one of potassium, sodium hydroxide.
The mixed volume ratio of phosphate buffer and acetone is 4-9:1 in step (2).
Sodium Metabisulfite in step (2), EDTA, 7-ACA mass ratio be 0.03-0.05:0.02-0.05:1.
The concentration of dilute hydrochloric acid is 15-20% in step (2).
Compared with prior art, the invention has the following beneficial effects:
(1) present invention can keep the stabilization of reacting liquid pH value, using phosphate buffer as solvent to solve to react The problem of adding lye repeatedly because of pH reduction in the process;
(2) a small amount of acetone is added in a solvent, it is miscellaneous can to remove in the reaction part during synthesizing TDA by the present invention Matter, to improve product purity;
(3) TDA yield prepared by the present invention can reach 110~115%, and purity is higher than 98%, and color is good, technique letter used List, solvent are mild, meet the energy-saving and emission-reduction requirement of country's promotion, mitigate environmental protection pressure, are suitable for industrialized production.
Specific embodiment
The present invention will be further described with reference to embodiments, but protection scope of the present invention is not limited only to this, the neck Domain professional changes to made by technical solution of the present invention, is within the scope of protection of the invention interior.
Embodiment 1
(1) phosphate buffer is prepared
Dipotassium hydrogen phosphate 0.59g, potassium dihydrogen phosphate 0.41g are weighed, purified water is added to dissolve and is settled to 1000mL, is shaken up The phosphate buffer that pH value is 7.8, it is spare.
(2) TDA is synthesized
500mL three-necked flask is taken, the phosphate buffer 1 80mL of Fresh is added, acetone 60mL is added while stirring Thiadiazoles 12g, is slowly added dropwise triethylamine 8g in 35 DEG C, is warming up to 60 DEG C wait be added dropwise, and 7- is added after all dissolutions ACA12g reacts 2h, adds Sodium Metabisulfite 0.6g, EDTA0.6g, and the reaction was continued, sample detection, remains < to 7-ACA 1.0%, reaction terminates, and is cooled to room temperature, in reaction solution be added dropwise 15% dilute hydrochloric acid adjust pH value be 3.8, growing the grain 30min, Ice water is cooled to 5 DEG C again, filters, and is washed 2 times with 100mL, 200mL acetone is washed 3 times, and TDA dry product is dried in vacuo to obtain in 60 DEG C 13.70g, yield are 1.14 (in terms of 7-ACA), content 98.3%.
Embodiment 2
(1) phosphate buffer is prepared
Disodium hydrogen phosphate 0.48g, potassium dihydrogen phosphate 0.41g are weighed, purified water is added to dissolve and is settled to 1000mL, is shaken up The phosphate buffer that pH is 8.0, it is spare.
(2) TDA is synthesized
500mL three-necked flask is taken, the phosphate buffer 260mL of Fresh is added, acetone 40mL is added while stirring Thiadiazoles 8g, is slowly added dropwise triethylamine 10.2g in 35 DEG C, is warming up to 65 DEG C wait be added dropwise, and 7- is added after all dissolutions ACA12g reacts 2h, adds Sodium Metabisulfite 0.6g, EDTA0.45g, and the reaction was continued, sample detection, remains to 7-ACA < 1.0%, reaction terminates, and is cooled to room temperature, and the dilute hydrochloric acid adjusting pH value that 18% is added dropwise in reaction solution is 4.0, growing the grain 40min, then ice water are cooled to 5 DEG C, filter, and are washed 2 times with 150mL, 200mL acetone is washed 3 times, is dried in vacuo to obtain TDA in 60 DEG C Dry product 13.62g, yield are 1.135 (in terms of 7-ACA), content 98.2%.
Embodiment 3
(1) phosphate buffer is prepared
Dipotassium hydrogen phosphate 2.72g is weighed, adds purified water to dissolve and is settled to 100mL.100mL is taken, 0.20mol hydroxide is added Sodium solution 84.8mL is added water and is diluted to the phosphate buffer that 400mL is 7.6 to get pH, spare.
(2) TDA is synthesized
500mL three-necked flask is taken, the phosphate buffer 270mL of Fresh is added, acetone 30mL is added while stirring Thiadiazoles 6g, is slowly added dropwise ammonium hydroxide 12g in 35 DEG C, is warming up to 68 DEG C wait be added dropwise, and 7-ACA12g is added after all dissolutions, 2.5h is reacted, Sodium Metabisulfite 0.36g, EDTA0.24g are added.Sample detection remains < 1.0%, reaction knot to 7-ACA Beam is cooled to room temperature, and it is 3.9 that certain 20% salt acid for adjusting pH value is added dropwise in reaction solution, and growing the grain 50min, then ice water are cooled to 0 DEG C, filter, with 120mL wash 2 times, 200mL acetone is washed 3 times, be dried in vacuo in 60 DEG C TDA dry product 13.35g, yield are 1.11 (in terms of 7-ACA), content 98.0%.

Claims (10)

1. a kind of synthetic method of Cefazolin Intermediate TDA, it is characterised in that: using phosphate buffer and acetone as solvent, Using 7-ACA and thiadiazoles as raw material, reacts under the action of catalyst, obtain TDA;
The catalyst is ammonium hydroxide or triethylamine.
2. the synthetic method of Cefazolin Intermediate TDA according to claim 1, it is characterised in that: 7-ACA and thiadiazoles Mass ratio be 1:0.5-1.
3. the synthetic method of Cefazolin Intermediate TDA according to claim 1, it is characterised in that: 7-ACA and catalyst Mass ratio be 1:0.8-1.0.
4. the synthetic method of Cefazolin Intermediate TDA according to claim 1, it is characterised in that: the following steps are included:
(1) it prepares phosphate buffer: buffer substance being dissolved in purified water, is shaken up, phosphate buffer is made;
(2) it synthesizes TDA: phosphate buffer and acetone being mixed, thiadiazoles and catalyst is sequentially added, is warming up to 60-70 DEG C, 7-ACA is added, reacts 1.5-3h, adds Sodium Metabisulfite and EDTA, the reaction was continued to 7-ACA residual quantity < 1.0%, instead It should terminate, be down to room temperature, it is 3.8-4.0 that dilute hydrochloric acid, which is added, and adjusts pH value, crystallization, then is cooled to 0~5 DEG C, filters, washs, does It is dry to get TDA product.
5. the synthetic method of Cefazolin Intermediate TDA according to claim 4, it is characterised in that: buffering in step (1) Substance is one of potassium dihydrogen phosphate, sodium dihydrogen phosphate and one of disodium hydrogen phosphate, dipotassium hydrogen phosphate, sodium hydroxide Mixture.
6. the synthetic method of Cefazolin Intermediate TDA according to claim 4, it is characterised in that: phosphoric acid in step (1) The pH value of salt buffer is 7.6-8.0.
7. the synthetic method of Cefazolin Intermediate TDA according to claim 4, it is characterised in that: phosphoric acid in step (2) The mixed volume ratio of salt buffer and acetone is 4-9:1.
8. the synthetic method of Cefazolin Intermediate TDA according to claim 4, it is characterised in that: laid particular stress in step (2) Sodium sulfite, EDTA, 7-ACA mass ratio be 0.03-0.05:0.02-0.05:1.
9. the synthetic method of Cefazolin Intermediate TDA according to claim 4, it is characterised in that: dilute salt in step (2) The concentration of acid is 15-20%.
10. the synthetic method of Cefazolin Intermediate TDA according to claim 4, it is characterised in that: analysis in step (2) Brilliant temperature is 20-25 DEG C, and the crystallization time is 30-50min.
CN201811581537.6A 2018-12-24 2018-12-24 The synthetic method of Cefazolin Intermediate TDA Pending CN109336905A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811581537.6A CN109336905A (en) 2018-12-24 2018-12-24 The synthetic method of Cefazolin Intermediate TDA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811581537.6A CN109336905A (en) 2018-12-24 2018-12-24 The synthetic method of Cefazolin Intermediate TDA

Publications (1)

Publication Number Publication Date
CN109336905A true CN109336905A (en) 2019-02-15

Family

ID=65297198

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811581537.6A Pending CN109336905A (en) 2018-12-24 2018-12-24 The synthetic method of Cefazolin Intermediate TDA

Country Status (1)

Country Link
CN (1) CN109336905A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6374488A (en) * 1986-09-18 1988-04-04 Asahi Chem Ind Co Ltd Production of 7-aminocephalosporanic acid and derivative thereof
CN1594321A (en) * 2004-06-23 2005-03-16 哈药集团制药总厂 Process for preparing cephazoline three-position intermediate

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6374488A (en) * 1986-09-18 1988-04-04 Asahi Chem Ind Co Ltd Production of 7-aminocephalosporanic acid and derivative thereof
CN1594321A (en) * 2004-06-23 2005-03-16 哈药集团制药总厂 Process for preparing cephazoline three-position intermediate

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KAZUO KARIYONE ET AL.: "CEFAZOLIN, A NEW SEMISYNTHETIC CEPHALOSPORIN ANTIBIOTIC. I SYNTHESIS AND CHEMICAL PROPERTIES OF CEFAZOLIN", 《THE JOURNAL OF ANTIBIOTIC》 *
张秋荣等: "头孢替唑钠的合成工艺", 《中国药物化学杂志》 *

Similar Documents

Publication Publication Date Title
CN101613361B (en) Method for preparing cefoxitin sodium
CN107033161B (en) A kind of synthetic method of tazobactam
CN103539803A (en) Method for preparing ceftriaxone sodium
CN105399754B (en) A kind of preparation method of Cefamandole Nafate
CN113754647A (en) Synthesis method of sulfuryl pyraflufen-ethyl and intermediate thereof
CN109678744A (en) A kind of method that serialization prepares glycine
CN109336905A (en) The synthetic method of Cefazolin Intermediate TDA
CN107266473B (en) A kind of synthetic method of cefotaxime
CN109651401A (en) The preparation method of Cefuroxime Sodium
CN113880902A (en) Molnupiravir drug intermediate and preparation method thereof
CN101735250A (en) Ceftezole sodium compound with novel route
CN111533710B (en) Method for preparing cefotiam intermediate 2-aminothiazole-4-acetic acid by one-pot method
CN117417333A (en) Synthesis process of pyribenzoxim sulfone
CN101525340B (en) Method for synthesizing 7-phenylacetylamino-3-chloromethyl cephalosporin alkyl acid p-methoxybenzyl ester
CN110357903B (en) Synthetic method of tazobactam acid
CN107892676A (en) The preparation method of Cefdinir active thioester
CN113699209A (en) 7-ADCA recovery method
CN105732457A (en) Method for preparing succinimide with succinic acid fermentation liquor
CN109912625A (en) A kind of process reducing cefotaxime impurity H
CN105294734A (en) Method for preparing cefonicid dibenzyl ethylenediamine salt
CN107235857B (en) A kind of preparation method of cyclohexanone oxime
CN104356155B (en) Preparation method of (S)-tert-butyldimethylsilyloxy-glutaramate
CN115784978B (en) Method for synthesizing 2-amino-6-bromopyridine
CN110241167A (en) A kind of method that enzyme process prepares Mandokef sodio-derivative
CN112724089B (en) Synthesis process of 2-amino-3-bromo-6-chloropyrazine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190215